• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEUROPACE, INC. NEUROPACE RNS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEUROPACE, INC. NEUROPACE RNS SYSTEM Back to Search Results
Model Number DL-344-10-K
Device Problem Insufficient Information (3190)
Patient Problems Blurred Vision (2137); Loss of Vision (2139)
Event Date 07/17/2014
Event Type  Injury  
Event Description
In (b)(4) 2014 - the patient was implanted with the rns system.The neurostimulator was placed in the left temporal region with (1) depth lead (44cm, 10 mm) in l hippocampus, (1) depth lead (44cm, 3.5mm) in l amygdala.Patient first reported blurriness in his right lower visual field.The neurosurgeon noted "difficulty in right field of vision." patient continued to report persistent blurriness in right inferior quatrad and some troubles reading.The neurologist noted in clinic note that "he does not have a frank field cut." in (b)(6) 2014 - he was seen formally by the ophthalmologist.Ophthalmologist clinic note that there is an "area of vision loss and positive visual phenomenon.Area is close to natural blind spot but larger." in (b)(6) 2015 - the patient mentioned he was seeing an eye doctor about experiencing a visual field reduction after his implant.His condition has stayed the same.Physician adjusted the neurostimulator stimulation parameters to improve his efficacy as he is responding but not with the intent to effect his vision.Medications have remained stable and not changed during this time period.Of note is that the hippocampal depth lead used an occipital approach for placement.It is a possibility that this may have contributed to the event, but we have no information on certainty.
 
Manufacturer Narrative
(b)(4).The rns neurostimulator and leads remain implanted for detection and treatment of patients intractable partial onset epilepsy.Patient appears to be responding to treatment.Device remains implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROPACE RNS SYSTEM
Type of Device
NEUROPACE RNS SYSTEM
Manufacturer (Section D)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer (Section G)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer Contact
ramona gonis
455 n. bernardo ave.
mountain view, CA 94043
6502382788
MDR Report Key4840740
MDR Text Key5911357
Report Number3004426659-2015-00001
Device Sequence Number1
Product Code PFN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 06/12/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/12/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberDL-344-10-K
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/18/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age37 YR
-
-